Learn More
BACKGROUND In the NIBIT-M1 study, we reported a promising activity of ipilimumab combined with fotemustine in metastatic melanoma (MM) patients with or without brain metastases. To corroborate these(More)
The purpose of this study was to review the results of a single-center experience in the management of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) using a sophisticated(More)
e19738 Background: We designed a case-control phase II open, prospective non-randomized trial in "fit" elderly (≥65 yo) cancer patients compared to well-matched adult (45-65 yo) cancer patients to(More)
  • 1